Incannex Healthcare Financials

IXHL Stock  USD 1.98  0.01  0.51%   
Based on the measurements of operating efficiency obtained from Incannex Healthcare's historical financial statements, Incannex Healthcare Ltd is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, Incannex Healthcare's Common Stock Shares Outstanding is quite stable compared to the past year. Total Liabilities is expected to rise to about 6.1 M this year, although the value of Short and Long Term Debt Total will most likely fall to about 354.4 K. Key indicators impacting Incannex Healthcare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.742.8829
Notably Down
Pretty Stable
The financial analysis of Incannex Healthcare is a critical element in measuring its lifeblood. Investors should not minimize Incannex Healthcare's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(17.54 Million)

  
Understanding current and past Incannex Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Incannex Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Incannex Healthcare's assets may result in an increase in income on the income statement.

Incannex Healthcare Stock Summary

Incannex Healthcare competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. Incannex Healthcare Limited was incorporated in 2001 and is based in Melbourne, Australia. Incannex Healthcare is traded on NASDAQ Exchange in the United States.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45333L1061
CUSIP45333F109 45333L106
LocationAustralia
Business Address8 Century Circuit,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.incannex.com
Phone61 4 0984 0786
CurrencyUSD - US Dollar

Incannex Healthcare Key Financial Ratios

Incannex Healthcare Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets2.9M7.0M26.1M58.6M17.0M14.6M
Other Current Liab330.9K392.1K1.1M1.9M4.8M5.1M
Net Debt(2.5M)(6.9M)(25.8M)(21.6M)(5.5M)(5.2M)
Retained Earnings(22.3M)(33.0M)(40.4M)(52.1M)(110.7M)(105.1M)
Accounts Payable405.5K175.1K894.8K1.8M527K528.0K
Cash2.5M6.9M25.8M22.1M5.9M4.5M
Net Receivables284.0K127.0K219.3K256.5K10.0M10.5M
Total Liab736.4K567.3K1.4M3.0M5.8M6.1M
Total Current Assets2.9M7.0M26.1M23.0M16.2M17.0M
Common Stock23.5M34.5M59.6M99.8M2K1.9K
Other Current Assets17.3K36.1K419.8K1.7M10.7M11.2M
Inventory125.9K(178.1K)(337.5K)(416.2K)(10.0M)(9.5M)
Net Tangible Assets3.2M8.6M35.9M31.4M36.1M37.9M
Net Invested Capital3.2M8.6M52.1M84.1M11.2M10.7M
Net Working Capital3.2M8.6M52.1M30.8M10.6M16.4M
Capital Stock34.2M45.9M125.9M150.8M2K1.9K

Incannex Healthcare Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense85.1K4.5K2.7K6.3K5.6K5.4K
Operating Income(2.9M)(8.2M)(11.4M)(17.7M)(30.0M)(28.5M)
Ebit(2.9M)(8.2M)(14.9M)(20.5M)(18.6M)(17.7M)
Ebitda(2.8M)(8.2M)(3.6M)(20.4M)(18.5M)(17.6M)
Income Before Tax(2.7M)(8.2M)(14.9M)(20.0M)(18.4M)(17.5M)
Net Income(3.2M)(8.2M)(14.9M)(20.0M)(18.5M)(17.5M)
Income Tax Expense488.3K(2.7K)(3.6M)30K27K28.4K
Total Revenue415.6K1.9M782.4K1.0M12K11.4K
Gross Profit106.2K985.6K776.0K1.0M12K11.4K
Cost Of Revenue524.1K582.2K309.4K912.0K6.3K0.0
Net Interest Income4.5K2.7K9.1K362.8K206K216.3K
Interest Income4.5K2.7K9.1K362.8K206K216.3K

Incannex Healthcare Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash2.4M4.1M19.5M(2.7M)(16.3M)(15.4M)
Free Cash Flow(3.9M)(5.2M)(8.8M)(10.9M)(16.1M)(15.3M)
Other Non Cash Items598.0K2.9M(408.9K)(4.3K)7.8M4.6M
Capital Expenditures47.6K24.4K476.9K315.7K277K277.9K
Net Income(4.7M)(8.5M)(10.3M)(13.2M)(18.5M)(17.5M)
End Period Cash Flow2.5M6.9M25.8M22.1M5.9M4.5M
Investments13K29.3K0.0(476.9K)(277K)(263.2K)
Change To Netincome699.2K4.5M870.2K3.2M3.7M1.8M

Incannex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Incannex Healthcare's current stock value. Our valuation model uses many indicators to compare Incannex Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Incannex Healthcare competition to find correlations between indicators driving Incannex Healthcare's intrinsic value. More Info.
Incannex Healthcare Ltd is rated second overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At this time, Incannex Healthcare's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Incannex Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Incannex Healthcare Systematic Risk

Incannex Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Incannex Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Incannex Healthcare correlated with the market. If Beta is less than 0 Incannex Healthcare generally moves in the opposite direction as compared to the market. If Incannex Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Incannex Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Incannex Healthcare is generally in the same direction as the market. If Beta > 1 Incannex Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Incannex Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incannex Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Incannex Healthcare growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.19

At this time, Incannex Healthcare's Price Earnings To Growth Ratio is quite stable compared to the past year.

Incannex Healthcare November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Incannex Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Incannex Healthcare Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Incannex Healthcare Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Incannex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Incannex Healthcare's daily price indicators and compare them against related drivers.
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.36)
Revenue Per Share
0.001
Quarterly Revenue Growth
0.296
Return On Assets
(0.57)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.